Renault Group finalises a strategic partnership with Wandercraft, a leader in next generation robotics

Investment and Partnership - Renault Group has completed a minority investment in Wandercraft, a leader in medical self-balancing exoskeletons, to enhance its capabilities in robotics and automation [1][5] - The partnership aims to develop the Calvin family of next-generation robots for industrial applications, which will help alleviate workers from non-ergonomic tasks and improve productivity [2][3] Technological Advancements - Wandercraft's technology will be integrated with Renault Group's industrial expertise to scale up production of exoskeletons and robots, thereby reducing costs through design-to-cost and scaling [2][4] - Wandercraft has developed over 30 patents and operates more than 100 Atalante exoskeletons in hospitals globally, with plans to market a new personal exoskeleton, Eve, to assist quadriparetic individuals [7] Strategic Goals - The collaboration is expected to drive productivity by accelerating production time and reducing costs, allowing Renault Group to focus its workforce on more value-adding tasks [3][4] - Renault Group aims to achieve carbon neutrality in Europe by 2040, aligning with its commitment to sustainable and innovative mobility solutions [6][7]